IL6 and pancreatitis: Second, the DORADO project established IL-6 as the primary mediator of cytokines in post-pancreatitis diabetes, which exerts its glucose-regulating effects through insulin resistance (an increase in IL-6 by 1 ng/mL was associated with a 0.7% increase in insulin resistance (p = 0.038)) [94,95].